misonneh's library 929 articles Export Sort

Hide details

	Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. [My Copy] Biochimica et biophysica acta, Vol. 1770, No. 3. (March 2007), pp. 489-494. by Julia Kirchheiner, Angela Seeringer posted to review pharmacogenetics design cyp450 clinic 12lecture by misonneh on 2009-12-05 07:24:18 as along with 2 people guhjy skatsanis
	Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. [My Copy] European journal of clinical pharmacology, Vol. 64, No. 2. (February 2008), pp. 133-157. by Jürgen Brockmöller, Mladen V. Tzvetkov posted to review population phenotype pharmacogenetics methodology genetics design database association 12lecture by misonneh on 2009-12-04 18:06:31 as
	The Cochrane Collaboration and systematic reviews. [My Copy] The British journal of surgery, Vol. 94, No. 4. (April 2007), pp. 391-392. by M. Clarke posted to review practice methodology meta_analysis by misonneh on 2009-12-04 15:40:51 as along with 1 person gareth
	Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice. [My Copy] Clinical pharmacology and therapeutics, Vol. 84, No. 3. (September 2008), pp. 287-294. by S-M M. Huang, R. Temple posted to review race practice pharmacogenetics gxe clinic by misonneh on 2009-12-04 15:28:30 as
	Finding the missing heritability of complex diseases [My Copy] Nature In Nature, Vol. 461, No. 7265. (08 October 2009), pp. 747-753. by Teri A. Manolio, Francis S. Collins, Nancy J. Cox, et al.David B. Goldstein, Lucia A. Hindorff, David J. Hunter, Mark I. McCarthy, Erin M. Ramos, Lon R. Cardon, Aravinda Chakravarti, Judy H. Cho, Alan E. Guttmacher, Augustine Kong, Leonid Kruglyak, Elaine Mardis, Charles N. Rotimi, Montgomery Slatkin, David Valle, Alice S. Whittemore, Michael Boehnke, Andrew G. Clark, Evan E. Eichler, Greg Gibson, Jonathan L. Haines, Trudy F. C. Mackay, Steven A. McCarroll, Peter M. Visscher posted to review gwas genetics association by misonneh on 2009-12-02 10:38:45 as along with 19 people and 1 group xingxu talponer virolog timflutre daveGerrard leemachado lp2 natstreet ns6 balajis jclau liqbbi josepe daforerog fenghezi rdiaz carolep merpublic djkt Journal picks
	Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics. [My Copy] Pharmacogenomics, Vol. 10, No. 2. (February 2009), pp. 235-241. by Teri A. Manolio posted to review population gwas genetics association by misonneh on 2009-12-02 10:37:07 as
	The genomic applications in practice and prevention network. [My Copy] Genetics in medicine : official journal of the American College of Medical Genetics, Vol. 11, No. 7. (July 2009), pp. 488-494. by Muin J. Khoury, W. Gregory Feero, Michele Reyes, et al.Toby Citrin, Andrew Freedman, Debra Leonard, Wylie Burke, Ralph Coates, Robert T. Croyle, Karen Edwards, Sharon Kardia, Colleen McBride, Teri Manolio, Gurvaneet Randhawa, Rebekah Rasooly, Jeannette St Pierre, Sharon Terry, GAPPNet Planning Group posted to review prevention gwas genetics clinic by misonneh on 2009-12-02 10:36:21 as
	Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 23. (9 June 2009), pp. 9362-9367. by Lucia A. Hindorff, Praveen Sethupathy, Heather A. Junkins, et al.Erin M. Ramos, Jayashri P. Mehta, Francis S. Collins, Teri A. Manolio posted to phenotype gwas genetics association by misonneh on 2009-12-02 10:35:36 as along with 8 people xingxu liqbbi rdiaz guhjy zufar daforerog pkonings jsatkosk
	Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions. [My Copy] The pharmacogenomics journal, Vol. 9, No. 1. (26 February 2009), pp. 23-33. by M. R. Nelson, S-A A. Bacanu, M. Mosteller, et al.L. Li, C. E. Bowman, A. D. Roses, E. H. Lai, M. G. Ehm posted to review pharmacogenomics gwas adr by misonneh on 2009-12-02 10:33:42 as along with 4 people mingzhi turnersd wimufi sschurer
	Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. [My Copy] Clinical pharmacokinetics, Vol. 48, No. 12. (2009), pp. 761-804. by Shu-Feng F. Zhou posted to review phenotype genetics cyp2d6 by misonneh on 2009-11-30 10:39:53 as
	Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. [My Copy] Clinical pharmacokinetics, Vol. 48, No. 11. (2009), pp. 689-723. by Shu-Feng F. Zhou posted to review phenotype genetics cyp2d6 by misonneh on 2009-11-30 10:36:14 as
	Clustering and its application in multi-target prediction. [My Copy] Current opinion in drug discovery & development, Vol. 12, No. 1. (January 2009), pp. 98-107. by William Liu, Dale E. Johnson posted to pharmacogenetics database data_mining cyp450 by misonneh on 2009-11-30 07:38:54 as along with 1 person ramensky
	Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. [My Copy] Pharmacogenetics, Vol. 9, No. 5. (October 1999), pp. 539-549. by H. G. Xie, C. M. Stein, R. B. Kim, G. R. Wilkinson, D. A. Flockhart, A. J. Wood posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 12:00:28 as
	Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. [My Copy] Pharmacogenetics, Vol. 10, No. 5. (July 2000), pp. 373-388. by V. Ozdemir, W. Kalow, B. K. Tang, et al.A. D. Paterson, S. E. Walker, L. Endrenyi, A. D. Kashuba posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:59:25 as
	Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. [My Copy] Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 27, No. 1. (July 2002), pp. 105-119. by Bernard Lerer, Ronnen H. Segman, Heiner Fangerau, et al.Ann K. Daly, Vincenzo S. Basile, Roberto Cavallaro, Harald N. Aschauer, Robin G. McCreadie, Stephanie Ohlraun, Nicol Ferrier, Mario Masellis, Massimiliano Verga, Joachim Scharfetter, Marcella Rietschel, Roger Lovlie, Uriel Heresco H. Levy, Herbert Y. Meltzer, James L. Kennedy, Vidar M. Steen, Fabio Macciardi posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:56:36 as
	CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. [My Copy] Genetics in medicine : official journal of the American College of Medical Genetics, Vol. 7, No. 2. (February 2005), pp. 97-104. by Simon Sanderson, Jon Emery, Julian Higgins posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:54:27 as
	Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation. [My Copy] Dialogues in clinical neuroscience, Vol. 8, No. 1. (2006), pp. 85-94. by Bernard Lerer, Ronnen H. Segman posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:54:09 as
	Pharmacogenomic effect of cytochrome P450 2C9 polymorphisms in different populations. [My Copy] Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, Vol. 12, No. 2. (April 2006), pp. 219-222. by Viroj Wiwanitkit posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:51:20 as
	Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. [My Copy] The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), Vol. 10, No. 5. (October 2007), pp. 697-704. by Vincenzo De Luca, Daniel J. Mueller, Andrea de Bartolomeis, James L. Kennedy posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:50:52 as
	Assessing theoretical risk and benefit suggested by genetic association studies of CCR5: experience in a drug development programme for maraviroc. [My Copy] Antiviral therapy, Vol. 12, No. 2. (2007), pp. 233-245. by Jeremy Wheeler, Mary McHale, Vicky Jackson, Michelle Penny posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:50:26 as
	Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease. [My Copy] Alimentary pharmacology & therapeutics, Vol. 26, No. 5. (1 September 2007), pp. 643-652. by J. M. Van Dieren, B. E. Hansen, E. J. Kuipers, E. E. Nieuwenhuis, C. J. Van der Woude posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:47:28 as
	Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. [My Copy] Progress in neuro-psychopharmacology & biological psychiatry, Vol. 32, No. 8. (12 December 2008), pp. 1848-1853. by Renan P. Souza, Vincenzo De Luca, Giovanni Muscettola, et al.Daniela V. Rosa, Andrea de Bartolomeis, Marco Romano Silva, James L. Kennedy posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:45:45 as
	Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis. [My Copy] European journal of clinical pharmacology, Vol. 65, No. 4. (April 2009), pp. 365-375. by Jonatan D. Lindh, Lennart Holm, Marine L. Andersson, Anders Rane posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:43:55 as
	Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. [My Copy] The Journal of rheumatology, Vol. 36, No. 3. (March 2009), pp. 539-545. by Mark C. Fisher, Bruce N. Cronstein posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:40:38 as
	TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. [My Copy] The pharmacogenomics journal, Vol. 9, No. 3. (14 June 2009), pp. 161-167. by D. D. O'Rielly, N. M. Roslin, J. Beyene, A. Pope, P. Rahman posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:40:03 as
	Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. [My Copy] British journal of cancer, Vol. 96, No. 10. (21 May 2007), pp. 1504-1513. by E. de Azambuja, F. Cardoso, G. de Castro, et al.M. Colozza, M. S. Mano, V. Durbecq, C. Sotiriou, D. Larsimont, M. J. Piccart-Gebhart, M. Paesmans posted to review prognosis meta_analysis ki67 breast biomarker by misonneh on 2009-11-27 11:05:43 as
	Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis. [My Copy] The lancet oncology, Vol. 8, No. 5. (May 2007), pp. 411-419. by Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcom D. Mason posted to review prostate progression meta_analysis chemotherapy biomarker by misonneh on 2009-11-27 11:04:42 as
	Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. [My Copy] The oncologist, Vol. 12, No. 7. (July 2007), pp. 864-872. by Jeffrey Weber posted to review response immunity adr by misonneh on 2009-11-27 11:01:45 as along with 1 person calvin
	HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 1. (2 January 2008), pp. 14-20. by Alessandra Gennari, Maria Pia P. Sormani, Paolo Pronzato, et al.Matteo Puntoni, Mariantonietta Colozza, Ulrich Pfeffer, Paolo Bruzzi posted to randomized_controlled_trial pooling meta_anlaysis her2 chemotherapy breast anthracycline by misonneh on 2009-11-27 10:58:52 as
	Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 12. (20 April 2008), pp. 1987-1992. by Tomasz Burzykowski, Marc Buyse, Martine J. Piccart-Gebhart, et al.George Sledge, James Carmichael, Hans-Joachim J. Lück, John R. Mackey, Jean-Marc M. Nabholtz, Robert Paridaens, Laura Biganzoli, Jacek Jassem, Marijke Bontenbal, Jacques Bonneterre, Stephen Chan, Gul Atalay A. Basaran, Patrick Therasse posted to time_to_event survival statistics breast by misonneh on 2009-11-27 10:48:57 as
	Five-alpha-reductase Inhibitors for prostate cancer prevention. [My Copy] Cochrane database of systematic reviews (Online), No. 2. (2008) by T. J. Wilt, R. MacDonald, K. Hagerty, P. Schellhammer, B. S. Kramer posted to time_to_event review response prostate prevention meta_analysis chemotherapy biomarker 5-alpha_reductase by misonneh on 2009-11-27 10:46:07 as
	Multilocus Bayesian meta-analysis of gene-disease associations. [My Copy] American journal of human genetics, Vol. 84, No. 5. (May 2009), pp. 567-580. by Paul J. Newcombe, Claudio Verzilli, Juan P. Casas, Aroon D. Hingorani, Liam Smeeth, John C. Whittaker posted to statistics genetics bayesian association by misonneh on 2009-11-27 10:32:31 as along with 2 people jsatkosk daforerog
	ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. [My Copy] BMC medical genetics, Vol. 10 (04 June 2009), 50. by Georgios Kitsios, Elias Zintzaras posted to response pharmacogenetics meta_analysis genetics by misonneh on 2009-11-27 09:08:07 as
	Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. [My Copy] British journal of cancer, Vol. 101, No. 1. (7 July 2009), pp. 149-159. by P. de Graeff, A. P. Crijns, S. de Jong, et al.M. Boezen, W. J. Post, E. G. de Vries, A. G. van der Zee, G. H. de Bock posted to time_to_event ovarian meta_analysis her2 by misonneh on 2009-11-27 08:59:54 as
	Bayesian meta-analysis of genetic association studies with different sets of markers. [My Copy] American journal of human genetics, Vol. 82, No. 4. (April 2008), pp. 859-872. by Claudio Verzilli, Tina Shah, Juan P. Casas, et al.Juliet Chapman, Manjinder Sandhu, Sally L. Debenham, Matthijs S. Boekholdt, Kay Tee T. Khaw, Nicholas J. Wareham, Richard Judson, Emelia J. Benjamin, Sekar Kathiresan, Martin G. Larson, Jian Rong, Reecha Sofat, Steve E. Humphries, Liam Smeeth, Gianpiero Cavalleri, John C. Whittaker, Aroon D. Hingorani posted to statistics review methodology meta_analysis genetics bayesian by misonneh on 2009-11-27 08:55:18 as along with 2 people daforerog guhjy
	Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach. [My Copy] Pharmacogenetics and genomics, Vol. 17, No. 3. (March 2007), pp. 217-220. by Guy D. Leschziner, Toby Andrew, John Paul P. Leach, et al.David Chadwick, Alison J. Coffey, David J. Balding, David R. Bentley, Munir Pirmohamed, Michael R. Johnson posted to response resistance pharmacogenetics mdr1 gwas genetics epilepsy by misonneh on 2009-11-27 08:46:17 as
	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. [My Copy] The lancet oncology, Vol. 9, No. 10. (October 2008), pp. 962-972. by Helena Linardou, Issa J. Dahabreh, Dimitra Kanaloupiti, et al.Fotios Siannis, Dimitrios Bafaloukos, Paris Kosmidis, Christos A. Papadimitriou, Samuel Murray posted to review response pharmacogenetics meta_analysis genetics egfr_pathway by misonneh on 2009-11-27 08:42:08 as along with 1 person jfr
	Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. [My Copy] Epilepsia, Vol. 50, No. 4. (April 2009), pp. 898-903. by Facundo Garcia G. Bournissen, Myla E. Moretti, David N. Juurlink, Gideon Koren, Mugabe Walker, Yaron Finkelstein posted to review response pharmacogenetics meta_analysis mdr1 genetics epilepsy by misonneh on 2009-11-27 08:37:06 as
	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1313-1318. by Soumya Raychaudhuri, Brian P. Thomson, Elaine F. Remmers, et al.Stephen Eyre, Anne Hinks, Candace Guiducci, Joseph J. Catanese, Gang Xie, Eli A. Stahl, Robert Chen, Lars Alfredsson, Christopher I. Amos, Kristin G. Ardlie, Anne Barton, John Bowes, Noel P. Burtt, Monica Chang, Jonathan Coblyn, Karen H. Costenbader, Lindsey A. Criswell, Crusius, Jing Cui, Phillip L. De Jager, Bo Ding, Paul Emery, Edward Flynn, Pille Harrison, Lynne J. Hocking, Tom W. J. Huizinga, Daniel L. Kastner, Xiayi Ke, Fina A. S. Kurreeman, Annette T. Lee, Xiangdong Liu, Yonghong Li, Paul Martin, Ann W. Morgan, Leonid Padyukov, David M. Reid, Mark Seielstad, Michael F. Seldin, Nancy A. Shadick, Sophia Steer, Paul P. Tak, Wendy Thomson, Annette H. M. van der Helm-van Mil, Irene E. van der Horst-Bruinsma, Michael E. Weinblatt, Anthony G. Wilson, Gert J. Wolbink, Paul Wordsworth, David Altshuler, Elizabeth W. Karlson, Rene E. M. Toes, Niek de Vries, Ann B. Begovich, Katherine A. Siminovitch, Jane Worthington, Lars Klareskog, Peter K. Gregersen, Mark J. Daly, Robert M. Plenge posted to statistics pathway meta_analysis gwas grail genetics association by misonneh on 2009-11-25 05:58:27 as
	Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions [My Copy] PLoS Genet, Vol. 5, No. 6. (26 June 2009), e1000534. by Soumya Raychaudhuri, Robert M. Plenge, Elizabeth J. Rossin, et al.Aylwin C. Y. Ng, Shaun M. Purcell, Pamela Sklar, Edward M. Scolnick, Ramnik J. Xavier, David Altshuler, Mark J. Daly, International S. Consortium posted to statistics pathway methodology gwas grail genetics association by misonneh on 2009-11-25 05:55:18 as along with 8 people and 1 group ajbattle daed ns6 greg psique xingxu daforerog kimorley Journal picks
	The hallmarks of cancer. [My Copy] Cell, Vol. 100, No. 1. (7 January 2000), pp. 57-70. by D. Hanahan, R. A. Weinberg posted to review moa key cancer by misonneh on 2009-11-24 07:32:24 as along with 25 people bertelsen myzhang chemnerd1 ipark-kaist singhsh JeremyZucker Zephyrus rklancer guhjy kentsis Borelli jfr laurabailey archroad iskanbasal mhucka holmesjo SeungjoonOh cerami tibbitts waghsk zebkhan frohike catcremona gwenknight
	Epigenetics in cancer. [My Copy] The New England journal of medicine, Vol. 358, No. 11. (13 March 2008), pp. 1148-1159. by Manel Esteller posted to review key epigenetics cancer by misonneh on 2009-11-24 07:28:31 as along with 5 people and 1 group tonamswish suizifish srp33 guhjy frohike Bioinformatics
	SnapShot: the human DNA methylome in health and disease. [My Copy] Cell, Vol. 135, No. 6. (12 December 2008), pp. 1144-1144.e1. by Esteban Ballestar, Manel Esteller posted to review methylation mapping comments by misonneh on 2009-11-24 07:22:15 as along with 1 person guhjy
	Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome [My Copy] J. Natl. Cancer Inst., Vol. 97, No. 6. (16 March 2005), pp. 439-448. by Rowan T. Chlebowski, Zhao Chen, Garnet L. Anderson, et al.Thomas Rohan, Aaron Aragaki, Dorothy Lane, Nancy C. Dolan, Electra D. Paskett, Anne McTiernan, F. Alan Hubbell, Lucile L. Adams-Campbell, Ross Prentice posted to survival risk_factor review race disparities breast by misonneh on 2009-11-24 07:06:37 as
	Social Determinants of Black-White Disparities in Breast Cancer Mortality: A Review [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 17, No. 11. (November 2008), pp. 2913-2923. by Mary A. Gerend, Manacy Pai posted to disparities review race breast by misonneh on 2009-11-24 07:05:37 as
	Underlying Causes of the Black-White Racial Disparity in Breast Cancer Mortality: A Population-Based Analysis [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 14. (15 July 2009), pp. 993-1000. by Idan Menashe, William F. Anderson, Ismail Jatoi, Philip S. Rosenberg posted to risk_factor race population disparities breast by misonneh on 2009-11-24 07:04:37 as along with 2 people and 2 groups songpku Zephyrus Roswell Cancer Crosstalk Breast Cancer Reading Club
	Breast Cancer Racial Gap Examined: No Easy Answers to Explain Disparities in Survival [My Copy] JAMA, Vol. 290, No. 14. (8 October 2003), pp. 1838-1842. by Brian Vastag posted to race disparities comments breast by misonneh on 2009-11-24 07:02:38 as
	Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence. [My Copy] Breast cancer research and treatment, Vol. 114, No. 2. (March 2009), pp. 315-325. by Hetty E. Carraway, Shelun Wang, Amanda Blackford, et al.Mingzho Guo, Penny Powers, Stacie Jeter, Nancy E. Davidson, Pedram Argani, Kyle Terrell, James G. Herman, Julie R. Lange posted to time_to_event survival methylation gene_specific_methylation epigenetics breast by misonneh on 2009-11-24 06:57:05 as
	Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. [My Copy] Carcinogenesis, Vol. 29, No. 7. (July 2008), pp. 1459-1465. by Benjamin A. Rodriguez, Alfred S. Cheng, Pearlly S. Yan, et al.Dustin Potter, Francisco J. Agosto-Perez, Charles L. Shapiro, Tim H-M H. Huang posted to tamoxifen polycomb phenotype moa estrogen epigenetics breast by misonneh on 2009-11-24 06:51:57 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/author/

Result page: 1 2 3 4 5 6 7 8 9 10 Next

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

review	322
breast	263
genetics	175
epigenetics	162
methylation	153
pharmacogenetics	147
statistics	90
gwas	69
gene_specific_methylation	66
comments	65
biomarker	65
prognosis	61
association	59
meta_analysis	57
tamoxifen	53
chemotherapy	50
peripheral	47
moa	47
gxe	47
diet	43
folate	40
modeling	38
response	38
survival	36
resistance	36
guideline	35
prediction	33
global	33
adr	31
epidemiology	31
epistasis	30
prostate	28
korean	28
time_to_event	28
dynamic	28
technology	27
diagnosis	26
haplotype	26
cyp2d6	25
race	24
expression	23
neoadjuvant	22
database	21
colon	21
prevention	21
circ_dna	21
instability	21
environment	20
progression	19
phenotype	18
perspective	17
pooling	17
lung	17
risk_factor	17
clinic	16
line1	16
therapy	16
immunity	15
target_dna	14
invivo	13
1-carbon	13
randomized_controlled_trial	13
hr	13
kfdap_112909	13
tool	13
tutorial	12
age	12
5mdc	12
pk	11
mirna	11
data_mining	11
metastasis	11
gxg	11
hematology	11
design	11
estrogen	10
bladder	10
pathway	9
mdr1	9
exposure	9
her2	9
smoking	9
hormone	9
reproductive	8
esr1	8
fda	8
methodology	8
lifestyle	8
heterogeneity	8
cyp450	8
epilepsy	8
bias	8
cancer	8
gst	8
ivive	8
etiology	7
power	7
cnv	7
prenatal	7
hla	7
kim_	7
mthfr	7
trend	7
dnmt	7
subtypes	7
metabolism	7
drug_discovery	6
summary	6
system_biology	6
hyper_hypo	6
alcohol	6
cell	6
pcb	6
cohort	6
histone	6
maternal	6
dna_repair	6
carbamazepine	6
ddi	6
inheritance	5
fundamental_concept_s1	5
chemoprevention	5
mortality	5
benign	5
mgmt	5
array	5
translation	5
microarray	5
mhc	5
pet	5
nos3	5
intervention	5
cervix	5
ntissue	4
disparities	4
observation	4
leukemia	4
detection	4
bmd	4
balanced	4
cns	4
refractory	4
population	4
pathology	4
triple-negative	4
bayesian	4
cimp	4
basal-like	4
transport	4
biobank	4
linkage	4
tsnp	4
asian_populations	4
public	3
toxicity	3
fu	3
practice	3
ros	3
ovarian	3
cyp1a1	3
antioxidant	3
demethylation	3
cytokine	3
swog	3
12lecture	3
cluster	3
intrauterine	3
mds	3
sult1e1	3
glioblastoma	3
molecular	3
metformin	3
sult1a1	3
statin	3
validation	3
risk_assessment	3
hitchhiking	3
aml	3
egfr_pathway	3
protocol	2
pharmacogenomics	2
fprp	2
decitabine	2
specimen	2
pharmacodynamic	2
classification	2
phase	2
isoflavone	2
testicular	2
genotype	2
polycomb	2
ugt	2
nutrition	2
diabetes	2
tpmt	2
immortalization	2
radiotherapy	2
oral	2
wnt	2
quantitative_traits	2
anthracycline	2
brain	2
finasteride	2
consorcium	2
ovary	2
lymphoma	2
grail	2
toxicology	2
bisphenol	2
caret	2
iron	2
feature_selection	2
slco1b1	2
s8897	2
key	2
hematopoiety	2
ki67	2
irinotecan	2
aromatase_inhibitor	2
mnsod	2
brca12	2
parent_study	2
comt	2
cyp2c19	2
kawasaki	2
allergy	2
epigenetic_therapy	2
insilico	2
cyp2e1	2
apoptosis	2
childhood	2
benzopyrene	2
brca	2
definition	2
endometrix	2
atm	2
nqo1	2
aspirin	2
lactation	1
compliance	1
meta_anlaysis	1
fastsnp	1
myc	1
multiple_myeloma	1
aldh1	1
temozolomide	1
illumina	1
prevalence	1
journal_club	1
pax2	1
endpoint	1
twin_study	1
xrcc3	1
cml	1
decision	1
benzene	1
aldh2	1
read_	1
histology	1
cell_cycle_control	1
paternal	1
sat2	1
mbd2	1
interleukin	1
ho1	1
xrcc1	1
liver	1
rank	1
acs	1
gpx1	1
cyp1a2	1
ugt1a1	1
methotrexate	1
dag	1
series	1
resonse	1
silencing_rna	1
cyp2c9	1
history	1
s100p	1
psychoses	1
fmr1	1
5-alpha_reductase	1
rcc	1
nhs	1
sfrp5	1
steroid	1
azacitidine	1
catechol	1
obesity	1
tgf	1
consortium	1
cyp3a4	1
dcic	1
peakbmd	1
nrf2	1
oralscc	1
cyp1b1	1
mrp3	1
maspin	1
nsaid	1
gstp1	1
osteoporosis	1
inflammtion	1
opg	1
assay	1
phytoestrogen	1
lipidadjust	1
mining	1
cbr3	1
antidepressant	1
scn	1
rfc	1
meternal	1
hnscc	1
cisplatin	1
polyphenol	1
hogg1	1
confounder	1
cyclophosphamide	1
mpo	1
parity	1
oncotypedx	1
cdk	1
alternative	1
tp53	1
nuclear_receptor	1
alkylating_agents	1
stromal_component	1
tea	1
cat	1
infection	1
abacavir	1
digoxin	1
p53	1
metabolomics	1
index	1
ecadherin	1
xpd	1
polymapr	1
plink	1
mapping	1
family_hx	1
sputum	1
src	1
networking	1
glioma	1
neurod1	1
proression	1
bmp	1
splicing	1
hpv	1
fun	1
no	1
invitro	1
peripheral_blood	1
qsar	1
diganosis	1
example	1
multitest	1
cyp19	1
casp8	1
integration	1
pharmacokinetic_variability	1
heritability	1
hif1a	1
tgm2	1
outcome	1
warfarin	1
immunoprecipitation	1

misonneh's library 929 articles Export Sort

misonneh's tags